Prediction of liver allograft fibrosis after transplantation for hepatitis C virus: Persistent elevation of serum transaminase levels versus necroinflammatory activity

Liver Transplantation

Volumn 6, Issue 1, 2000, Pages 44-53

  Pelletier, Shawn J ^a,b   Iezzoni, Julia C ^a   Crabtree, Traves D ^a   Hahn, Young S ^a   Sawyer, Robert G ^a   Pruett, Timothy L ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE;

ADULT; ARTICLE; CHOLESTATIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LIVER TRANSPLANTATION; MALE; PREDICTION; PRIORITY JOURNAL; RECURRENT INFECTION; RISK FACTOR; STEATOSIS; VIRUS LOAD;

EID: 0034049483     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500060111     Document Type: Article

References (40)

1. Wright TL, Pereira B. Liver transplantation for chronic viral hepatitis. Liver Transpl Surg 1995;1:30-42.
2. Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992;103:317-322.
3. Feray C, Samuel D, Thiers V, Gigou M, Pichon F, Bismuth A, et al. Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest 1992;89:1361-1365.
4. Konig V, Bauditz J, Lobeck H, Lusebrink R, Neuhaus P, Blumhardt G, et al. Hepatitis C virus reinfection in allografts after orthotopic liver transplantation. Hepatology 1992;16:1137-1143.
5. Chazouilleres O, Kim M, Combs C, Ferrell L, Bacchetti P, Roberts J, et al. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 1994;106:994-999.
6. Shah G, Demetris AJ, Gavaler JS, Lewis JH, Todo S, Starzl TE, et al. Incidence, prevalence, and clinical course of hepatitis C following liver transplantation. Gastroenterology 1992;103:323-329.
7. Shiffman ML, Contos MJ, Luketic VA, Sanyal AJ, Purdum PP III, Mills AS, et al. Biochemical and histologic evaluation of recurrent hepatitis C following orthotopic liver transplantation. Transplantation 1994;57:526-532.
8. Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, et al. Long-term outcome of hepatitis C infection after liver transplantation. N EnglJ Med 1996;334:815-820.
9. Weinstein JS, Poterucha JJ, Zein N, Wiesner RH, Persing DH, Rakela J. Epidemiology and natural history of hepatitis C infections in liver transplant recipients. J Hepatol 1995;22:154-159.
10. Feray C, Gigou M, Samuel D, Paradis V, Wilber J, David MF, et al. The course of hepatitis C virus infection after liver transplantation. Hepatology 1994;20:1137-1143.
11. Pessoi MG, Terrault NA, Ferrell LD, Detmer J, Kolberg J, Collins ML, et al. Hepatitis after liver transplantation: The role of the known and unknown viruses. Liver Transpl Surg 1998;4: 461-468.
12. Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology 1998;28:823-830.
13. Gretch DR, Bacchi CE, Corey L, dela Rosa C, Lesniewski RR, Kowdley K, et al. Persistent hepatitis C virus infection after liver transplantation: Clinical and virological features. Hepatology 1995;22:1-9.
14. Freeman RB, Tran S, Lee YM, Rohrer RJ, Kaplan MM. Serum hepatitis C RNA titers after liver transplantation are not correlated with immunosuppression or hepatitis. Transplantation 1996;61:542-546.
15. Herrero JI, de la Pena A, Quiroga J, Sangro B, Garcia N, Sola I, et al. Risk factors for recurrence of hepatitis C after liver transplantation. Liver Transpl Surg 1998;4:265-270.
16. Zhou H, Kim M, Ferrell L, Wright T. HCV genotyping of liver transplant (OLT) recipients: Relation to viremia and histology [abstract]. Hepatogastroenterolgy 1994;20:134A.
17. Feray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995;108:1088-1096.
18. Bayraktar Y, Van Thiel DH, Gurakar A. Hepatitis C and the controversies it creates relative to liver transplantation and autoimmune hepatitis. Hepatogastroenterology 1996;43:873-881.
19. Prieto M, Berenguer M, Rayon JM, Cordoba J, Arguello L, Carrasco D, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: Relationship with rejection episodes. Hepatology 1999;29: 250-256.
20. Dienstag JL, Isselbacher KJ: Chronic hepatitis. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, et al (eds). Harrison's principles of internal medicine, vol 2 (ed 14). New York: McGraw-Hill, 1998:1696-1704.
21. Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A 1991;88:2451-2455.
22. Anonymous. Banff schema for grading liver allograft rejection: An international consensus document. Hepatology 1997;25:658-663.
23. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995;19:1409-1417.
24. Daniel W. Simple linear regression and correlation. In: Daniel W (ed). Biostatistics: A foundation for analysis in the health sciences (ed 4). New York: Wiley, 1987:367-400.
25. Schluger LK, Sheiner PA, Thung SN, Lau JY, Min A, Wolf DC, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996;23:971-976.
26. Dickson RC, Caldwell SH, Ishitani MB, Lau JY, Driscoll CJ, Stevenson WC, et al. Clinical and histologic patterns of early graft failure due to recurrent hepatitis C in four patients after liver transplantation. Transplantation 1996;61:701-705.
27. Rosen HR, Chou S, Corless CL, Gretch DR, Flora KD, Boudousquie A, et al. Cytomegalovirus viremia: Risk factor for allograft cirrhosis after liver transplantation for hepatitis C. Transplantation 1997;64:721-726.
28. Manez R, Mateo R, Tabasco J, Kusne S, Starzl TE, Duquesnoy RJ. The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation. Transplantation 1995;59:640-642.
29. Loinaz C, Lumbreras C, Gonzalez-Pinto I, Colina F, Gomez R, Fuertes A, et al. High incidence of posttransplant hepatitis and chronic rejection associated with hepatitis C virus infection in . liver transplant recipients. Transplant Proc 1995;27:1217-1218.
30. Sheiner PA, Schwartz ME, Mor E, Schluger LK, Theise N, Kishikawa K, et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology 1995;21:30-34.
31. Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, et al. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Am J Gastroenterol 1997;92:1453-1457.
32. Singh N, Gayowski T, Ndimbie OK, Nedjar S, Wagener MM, Yu VL. Recurrent hepatitis C virus hepatitis in liver transplant recipients receiving tacrolimus: Association with rejection and increased immunosuppression after transplantation. Surgery 1996;119:452-456.
33. Fukumoto T, Berg T, Ku Y, Bechstein WO, Knoop M, Lemmens HP, et al. Viral dynamics of hepatitis C early after orthotopic liver transplantation: Evidence for rapid turnover of serum virions. Hepatology 1996;24:1351-1354.
34. Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM. The pathology of hepatitis C. Hepatology 1992;15:567-571.
35. Lefkowitch JH, Schiff ER, Davis GL, Perrillo RP, Lindsay K, Bodenheimer HC Jr, et al. Pathological diagnosis of chronic hepatitis C: A multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group. Gastroenterology 1993;104:595-603.
36. Baiocchi L, Tisone G, Palmieri G, Rapicetta M, Pisani F, Orlando G, et al. Hepatic steatosis: A specific sign of hepatitis C reinfection after liver transplantation. Liver Transpl Surg 1998;4: 441-447.
37. Hourigan LF, Macdonald GA, Purdie D, Whitehall VH, Shorthouse C, Clouston A, et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 1999;29:1215-1219.
38. Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Ishibashi K, Matsuura Y, et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 1997;78:1527-1531.
39. Koike K, Moriya K, Ishibashi K, Matsuura Y, Suzuki T, Saito I, et al. Expression of hepatitis C virus envelope proteins in transgenic mice. J Gen Virol 1995;76:3031-3038.
40. Doughty AL, Spencer JD, Cossart YE, McCaughan GW. Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels. Liver Transpl Surg 1998;4:15-21.